Related Experiment Video
Updated: Feb 5, 2026

Author Spotlight: Optimizing the Rearing Procedure of Germ-Free Wasps
Published on: July 21, 2023
Management of Refractory Germ Cell Cancer
1From Genitourinary Medical Oncology, Department of Urology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Abstract:
Over the past 5 decades, the use of well-validated, guideline-based strategies has resulted in high cure rates in newly diagnosed patients with germ cell cancer. However, about 30% of those with metastatic disease at initial presentation will experience refractory disease. Salvage treatment is far more complex and less validated than first-line treatment because it is rare, patient cohorts are more heterogeneous, and prognostic factors seem to have greater impact. Prior to the initiation of any salvage treatment, several considerations must be made, including assessment of known prognostic factors and choice of the optimal salvage strategy. Evaluation of patients according to their disease biology, response to prior treatment, and the extent of their tumor burden at the time of salvage treatment is crucial for establishing the optimal salvage strategy. Patients with metastatic germ cell cancer in whom adequate cisplatin-based first-line chemotherapy fails should be included in the ongoing randomized TIGER trial comparing conventional-dose chemotherapy with high-dose chemotherapy as first salvage treatment. Outside this trial, patients may be treated with conventional or high-dose chemotherapy depending on the presence or absence of adverse prognostic factors, availability of resources, and patient and physician preferences.
Insights
Germ cell cancer patients with refractory disease need tailored salvage treatment. Optimal strategies depend on disease biology, prior response, and tumor burden, with chemotherapy options varying based on prognostic factors.
Area of Science:
- Oncology
- Medical Research
Background:
- Germ cell cancer (GCC) has high cure rates with first-line therapy.
- Approximately 30% of metastatic GCC patients develop refractory disease.
- Salvage treatment for refractory GCC is complex and less validated than first-line options.
Purpose of the Study:
- To outline considerations for optimal salvage treatment strategies in refractory metastatic GCC.
- To discuss the factors influencing the choice between conventional and high-dose chemotherapy for salvage therapy.
Main Methods:
- Review of prognostic factors and treatment considerations for refractory GCC.
- Discussion of patient stratification based on disease biology, prior treatment response, and tumor burden.
- Reference to the TIGER trial comparing chemotherapy regimens for first salvage treatment.
Main Results:
- Salvage treatment complexity is driven by rarity, patient heterogeneity, and prognostic factor impact.
- Individualized patient evaluation is crucial for selecting the best salvage approach.
- Treatment decisions involve assessing prognostic factors, resources, and patient/physician preferences.
Conclusions:
- Optimal salvage strategies for refractory metastatic GCC require careful patient assessment.
- The TIGER trial offers a platform for comparing chemotherapy doses in first salvage.
- Treatment choices outside the trial should be guided by prognostic factors and practical considerations.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Managing Impressions

